These press releases are intended for business journalists and analysts/investors
INTERNATIONAL MEN’S HEALTH WEEK
- Life interrupted for Australian men as 1 in 3 over 50 affected by BPH
- New Prostate Health campaign urges men affected to consult GP
GSK’s respiratory medicine Breo Ellipta (fluticasone furoate/vilanterol trifenatate 100/25mcg and 200/25mcg) continues to be available to appropriate patients with asthma and COPD on the PBS.
GSK has the utmost sympathy for the people who have been, and are, afflicted by arachnoiditis. It can be a very debilitating and painful condition.
Arachnoiditis has a range of possible causes such as spinal injury, surgery and infection. However, it is difficult to determine the causality of arachnoiditis.
We are one of the world’s largest science-led pharmaceutical and healthcare companies. Each year we research, manufacture and sell innovative medicines, vaccines and healthcare products for millions of people across the world, helping them to do more, feel better and live longer.